Achieve Life Sciences
ACHV
41 hedge funds and large institutions have $64.9M invested in Achieve Life Sciences in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
620% more call options, than puts
Call options by funds: $1.63M | Put options by funds: $226K
478% more capital invested
Capital invested by funds: $11.2M → $64.9M (+$53.7M)
157% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 7
37% more funds holding
Funds holding: 30 → 41 (+11)
35.18% more ownership
Funds ownership: 12.88% → 48.06% (+35%)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$26.5M |
| 2 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$10.9M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.74M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$3.88M |
| 5 |
ACM
Altium Capital Management
New York
|
+$3.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
-$1.22M |
| 2 |
Walleye Capital
New York
|
-$340K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$222K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$191K |
| 5 |
Squarepoint
New York
|
-$95.2K |
ACHV Hedge Fund Activity: Q1 2024 in Review
41 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2024, worth a combined $64.9M — up 478% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ACHV positions and 7 closed out — a net gain of 11 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $26.5M. The largest seller was Shay Capital, cutting an estimated $1.22M.
- 41 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2024, up from 30 in Q4 2023.
- Funds reported $64.9M of Achieve Life Sciences stock for Q1 2024, up 478% quarter-over-quarter.
- 18 funds opened new Achieve Life Sciences positions in Q1 2024 and 7 closed out, a net change of +11 holders.
- The largest Achieve Life Sciences buyer in Q1 2024 was Franklin Resources, an estimated $26.5M added.
- The largest Achieve Life Sciences seller in Q1 2024 was Shay Capital, an estimated $1.22M sold.
Based on aggregated 13F filings for Q1 2024.